Westchester Capital Management (Nebraska)’s Merck MRK Stock Holding History

Westchester Capital Management (Nebraska)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-161	Closed	-$13K	–	42
2019 Q1	$13K	Hold	161	–	–	0.01%	33
2018 Q4	$12K	Buy	+161	New	+$11.4K	0.01%	31
2014 Q3	–	Sell	-1,023	Closed	-$56K	–	49
2014 Q2	$56K	Hold	1,023	–	–	0.03%	36
2014 Q1	$55K	Hold	1,023	–	–	0.03%	37
2013 Q4	$49K	Hold	1,023	–	–	0.03%	37
2013 Q3	$46K	Hold	1,023	–	–	0.03%	37
2013 Q2	$45K	Buy	+1,023	New	+$45.7K	0.03%	38

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westchester Capital Management (Nebraska)'s MRK Position: Q2 2019 in Review

Westchester Capital Management (Nebraska) sold out of Merck (MRK) in Q2 2019, closing a stake of 161 shares — an estimated $13K sold.

Westchester Capital Management (Nebraska) first reported a position in MRK in Q2 2013 and held it in 7 quarters. The position peaked at $56K in Q2 2014. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

Westchester Capital Management (Nebraska) reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
Westchester Capital Management (Nebraska) sold 161 Merck shares in Q2 2019, an estimated $13K.
Westchester Capital Management (Nebraska) first reported a position in Merck in Q2 2013 and held it in 7 quarters.
Westchester Capital Management (Nebraska)'s Merck position peaked at $56K in Q2 2014.
2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Westchester Capital Management (Nebraska)'s 13F filing for Q2 2019, filed 5 Aug 2019.